What medications are safe and effective for heartburn during pregnancy? by Koenig, Clint (Clint J.), 1971-
April 2001 (Vol. 50, No. 4) 
 Clinical Inquiries 
FROM THE FAMILY PRACTICE INQUIRIES NETWORK 
What medications are safe and 
effective for heartburn during 
pregnancy? 
Clint  J.  Koenig,  MD 
University of Missouri-Columbia 
  EVIDENCE-BASED ANSWER 
Ranitidine is the best-studied agent effective for treatment of heartburn in pregnancy. Some antacids are 
effective, but it may be prudent to avoid them in the first trimester until better safety studies are published. 
Although sucralfate, metoclopromide, and the proton pump inhibitors are probably safe in pregnancy, there are 
no data about their efficacy. (Grade of Recommendation: B [limited randomized controlled trials of short 
duration and small sample size]) 
  RECOMMENDATIONS FROM OTHERS 
Standard texts suggest that antacids1 or histamine (H2) blockers2 be used as first-line agents for reflux. Burrow 
and Duffyz3 recommend a stratified approach with antacids followed by H2-blockers, reserving the use of proton 
pump inhibitors for the more severe cases. 
  EVIDENCE SUMMARY 
Heartburn affects 30% to 50% of pregnancies and occurs primarily in the second and third trimesters.4 Lifestyle 
changes and dietary modification are recommended as initial measures for relief of symptoms. 
Antacids 
Each of the 3 identified placebo-controlled trials of antacid therapy had significant methodologic limitations. 
Aluminum phosphate more frequently produced complete relief of moderate to severe heartburn at 60 minutes 
compared with placebo (P <.001; number needed to treat [NNT] = 2.1 for mild heartburn and 20 for severe).5 
Patients who received a combination of magnesium and aluminum hydroxide for 7 days had no more relief of 
symptoms than the placebo group.6 Atlay and colleagues7 found that sodium bicarbonate significantly reduced 
reflux symptoms compared with placebo (P=.021; NNT=6.0). 
There are limited data regarding the safety of antacids during pregnancy. A single case-control study found a 
higher rate of congenital anomalies in children of women who took antacids in the first trimester (unadjusted 
odds ratio calculated from data=2.36; P <.05).8 This association was not detected when studied over the entire 
pregnancy. The rate of malformations was not different for magnesium, aluminum, and bicarbonate. The 
association could well be due to recall bias or other systematic biases inherent in case-control methodology. 
H2-Blockers 
The only identified studies of H2-blockers evaluated ranitidine. A 4-week double-blind randomized control trial 
found that ranitidine 150 mg twice daily reduced patient symptoms by 44% over placebo (P <.05).9 This study 
was limited by its short duration (<1 month) and small sample size (N=30). A 2-week study that compared 
antacids plus ranitidine to antacids alone found a 52% decrease in symptoms in the ranitidine group and a 44% 
reduction in the antacid-alone group.10 Ranitidine, cimetidine, and famotidine are US Food and Drug 
Administration (FDA) pregnancy category B (no demonstrated risk). 
Proton Pump Inhibitors 
In nonpregnant adults, proton pump inhibitors are more effective than antacids and H2-blockers for 
gastroesophageal reflux disease (GERD). No cohort or control studies have been performed on their efficacy in 
pregnancy. On the basis of animal studies, omeprazole is a category C drug (potential benefit of use should 
outweigh potential risks). A cohort study of 113 women found no associated anomalies (relative risk=1.94; 95% 
confidence interval, 0.36-10.36).11 Pantoprazole, lansoprazole and rabeprazole are category B medications. 
Other Agents 
Metoclopramide and sucralfate have been used in nonpregnant adults with GERD. Although both are category 
B, there are no data about their effectiveness for heartburn during pregnancy. 
CLINICAL COMMENTARY 
Donald  N.  Marquardt,  PhD, MD 
Iowa Health Physicians Cedar Rapids 
Heartburn along with morning sickness and back pain frequently diminishes the joy of 
pregnancy. Simple nonpharmacologic solutions such as frequent small meals, remaining 
upright after eating, and elevating the head of the bed will often suffice. The traditional use 
of agents in their order of development (antacids, H2-blockers, then proton pump inhibitors) 
finds some justification in this review for selected agents. Particularly enlightening was the 
rationale for specific agents: aluminum phosphate has efficacy as an antacid; ranitidine is 
the only studied H2-blocker; and there are 3 FDA category B proton pump inhibitors 
(pantoprazole, lansoprazole, and rabeprazole). Specific recommendations for these agents 
would improve patient benefit with a minimum of therapeutic trials frustrating both patient 
and physician. 
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